HSPA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.002000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.689600E-01
Normal-vs-Stage2
3.247600E-01
Normal-vs-Stage3
6.776400E-01
Normal-vs-Stage4
1.619420E-01
Stage1-vs-Stage2
2.706400E-02
Stage1-vs-Stage3
9.586600E-01
Stage1-vs-Stage4
1.872560E-01
Stage2-vs-Stage3
4.622200E-01
Stage2-vs-Stage4
2.254400E-01
Stage3-vs-Stage4
1.704580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.178000E-01
Normal-vs-AfricanAmerican
6.806200E-02
Normal-vs-Asian
3.169800E-01
Caucasian-vs-AfricanAmerican
6.357800E-01
Caucasian-vs-Asian
7.140800E-01
AfricanAmerican-vs-Asian
8.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.942000E-01
Normal-vs-Female
2.965600E-01
Male-vs-Female
2.746600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.163200E-01
Normal-vs-Age(41-60Yrs)
1.827160E-01
Normal-vs-Age(61-80Yrs)
3.771800E-01
Normal-vs-Age(81-100Yrs)
1.724190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.771800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.902200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.146800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.566100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.543500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.567000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.013800E-01
Normal-vs-Daily Drinker
3.538800E-01
Normal-vs-Weekly Drinker
3.272000E-01
Normal-vs-Occasional Drinker
2.751000E-01
Normal-vs-Social Drinker
1.751380E-01
Non Drinker-vs-Daily Drinker
8.633600E-01
Non Drinker-vs-Weekly Drinker
3.497400E-01
Non Drinker-vs-Occasional Drinker
1.305600E-01
Non Drinker-vs-Social Drinker
4.410000E-01
Daily Drinker-vs-Weekly Drinker
3.932400E-01
Daily Drinker-vs-Occasional Drinker
1.928590E-01
Daily Drinker-vs-Social Drinker
4.753600E-01
Weekly Drinker-vs-Occasional Drinker
6.526000E-01
Weekly Drinker-vs-Social Drinker
7.787800E-01
Occasional Drinker-vs-Social Drinker
4.116800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.888600E-01
Normal-vs-Grade 2
4.364600E-01
Normal-vs-Grade 3
3.207200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.095800E-01
Grade 1-vs-Grade 3
7.452400E-01
Grade 1-vs-Grade 4
5.888600E-01
Grade 2-vs-Grade 3
8.068800E-01
Grade 2-vs-Grade 4
4.364600E-01
Grade 3-vs-Grade 4
3.207200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.374600E-01
Normal-vs-NonDiabetic
2.946000E-01
Diabetic-vs-NonDiabetic
9.448000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.086600E-01
Normal-vs-NoPancreatitis
3.022400E-01
Pancreatitis-vs-NoPancreatitis
8.844600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.937810E-01
Normal-vs-N1
3.291000E-01
N0-vs-N1
5.512200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.292600E-01
Normal-vs-TP53-NonMutant
4.649000E-01
TP53-Mutant-vs-TP53-NonMutant
2.895900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
